Is GRN Holding Corporation (GRNF) a Buy, Sell, or Hold?
OTC : GRNF
GRN Holding Corporation
$0.039 USD
$0.0 (-2.26%)
- Volume
- 43.87K
- Average Volume
- 164.44K
- Market Capitalization
- $1.37M
- P/E Ratio
- -16.96
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $0.20
- Year Low
- $0.01
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.00
Company Overview
OTC
Donald J. Steinberg
Shell Companies
Financial Services
GRNF
N/A
US
USD
Liquidity Metrics
0.00
0.00
0.00
0.00
0.00
Sales & Valuation
-$
0.00
0.74
-60.91
0.00
Profitability
-$0.0023
-$56804
0.00%
0.00%
-3.48%
-4.17%
P/E Metrics
-16.96
-0.19
-0.19
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
-10.99
3/9
-$54064.0
$1.36M
$54069.0
-$52114.0
Key Metrics (TTM)
$1.37M
0.00
-25.54
0.00
-3.48%
-4.34%
-5.85%
-1.64%
0 days
Company Executives
| Name | Title |
|---|---|
| Donald J. Steinberg | Chief Executive Officer & Director |
Poll Results
No votes yet today — be the first to share your view!
About GRN Holding Corporation (OTC:GRNF) Stock
GRN Holding Corporation currently possesses no significant business operations, and its primary objective is to finalize a merger with another enterprise. In the past, the company concentrated its efforts on the exploration and development of gold resources. Established in 2010, it was initially named Discovery Gold Corporation until its rebranding as GRN Holding Corporation in September 2019. The firm's main office is located in Seattle, Washington. ...
Denali Therapeutics: 'Strong Buy' On AVLAYAH Approval And End Of 2026 FTD-GRN Data
2026-05-27 07:54:16
Denali Therapeutics (DNLI) maintains a "Strong Buy" rating following FDA Accelerated Approval of AVLAYAH for Hunter Syndrome and robust pipeline momentum. Company's DNL593 for FTD-GRN is differentiated by restoring both extracellular and lysosomal PGRN; phase 1/2 data readout expected by end of 2026. AVLAYAH's full approval depends on confirmatory COMPASS study results; commercial performance remains unproven post-April 2026 launch.
Frequently Asked Questions
-
What is the current GRN Holding Corporation (GRNF) stock price?
-
GRN Holding Corporation(OTC:GRNF) stock price is $0.039 in the last trading session. During the trading session, GRNF stock reached the peak price of $0.2 while $0.005 was the lowest point it dropped to. The percentage change in GRNF stock occurred in the recent session was --2.26% while the dollar amount for the price change in GRNF stock was -$0.0.
-
GRNF's industry and sector of operation?
-
The OTC listed GRNF is part of Shell Companies industry that operates in the broader Financial Services sector.
-
Who are the executives of GRNF?
-
Donald J. Steinberg | Chief Executive Officer & Director
|
|
|
| -
How many employees does GRNF have?
-
Number of GRNF employees currently stands at None. GRNF operates from 1700 Seventh Avenue, Seattle, WA 98101, US.
-
Link for GRNF official website?
-
Official Website of GRNF is: https://www.aimalaboratories.com
-
How do I contact GRNF?
-
GRNF could be contacted at phone #425 830 1192 and can also be accessed through its website. GRNF operates from 1700 Seventh Avenue, Seattle, WA 98101, US.
-
How many shares of GRNF are traded daily?
-
The average number of GRNF shares traded daily for last 3 months was 164.44K.
-
What is the market cap of GRNF currently?
-
The market value of GRNF currently stands at $1.37M with its latest stock price at $0.039